Sangamo Therapeutics

SGMO

Sangamo Therapeutics, Inc. (previously known as Sangamo Biosciences, Inc.) is an American biotechnology company based in Brisbane, California. It applies cell and gene therapy to combat haemophilia and other genetic diseases.

Insider trades and stock quote 2023-2025

All insider trades at Sangamo Therapeutics

Subscribe RSS
DateTypeInsiderPositionØ-PriceVolume
9/26/2023 SellIdec Pharmaceuticals Corp Ten Percent Owner $0.5 $3,000,000
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)